Quarterly report pursuant to Section 13 or 15(d)

Organization and Nature of Operations (Details Textual)

v3.19.2
Organization and Nature of Operations (Details Textual) - USD ($)
1 Months Ended
Oct. 25, 2017
Oct. 19, 2016
Oct. 18, 2016
Jun. 30, 2019
Organization and Nature of Operations (Textual)        
Reverse split ratio     1:4  
Ownership percentage       40.00%
Avalon Healthcare System, Inc. [Member]        
Organization and Nature of Operations (Textual)        
Business acquired percentage   100.00%    
Exchange for common stock   50,000,000    
Percentage of capital stock   100.00%    
Ownership percentage       100.00%
GenExosome Technologies Inc. [Member]        
Organization and Nature of Operations (Textual)        
Acquired shares 600      
Consideration amount $ 1,326,087      
Common stock shares 500,000      
Ownership percentage       60.00%
Consideration of cash payment amount $ 450,000      
GenExosome Technologies Inc. [Member] | Asset Purchase Agreement [Member]        
Organization and Nature of Operations (Textual)        
Ownership percentage 60.00%      
Dr. Zhou [Member]        
Organization and Nature of Operations (Textual)        
Consideration amount $ 876,087      
Common stock shares 500,000      
Ownership percentage 40.00%      
Common stock issued 400